🔎 Trials Near Me

Domov › Rak pljuč › New York › Greenburgh

Klinične študije za Rak pljuč v Greenburgh, NY

17 študij za Rak pljuč išče udeležence na lokacijah v Greenburgh in okolici (v razdalji približno 30 milj). Odprite študijo, da vidite, kdo lahko sodeluje in kako kontaktirati ekipo.

Uradno besedilo študije (angleško)

Iščete udeležence za študijo? Predstavite jo na vrhu te strani — $99 za 30 dni →

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Vključevanje udeležencevFaza 3
  • Phelps Memorial Hospital Center, Sleepy Hollow · 4 mi stran
  • Dickstein Cancer Treatment Center, White Plains · 4 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT04267848

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Vključevanje udeležencevFaza 3
  • Dickstein Cancer Treatment Center, White Plains · 4 mi stran
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 5. okt. 2026 · NCT04181060

Adding Certolizumab to Chemotherapy + Nivolumab in People Who Have Lung Cancer That Can Be Treated With Surgery

Vključevanje udeležencevFaza 2
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 2. okt. 2026 · NCT04991025

Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer

Vključevanje udeležencevFaza 2
  • MSK Westchester, East White Plains · 5 mi stran
  • MSK Bergen., Montvale · 9 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 28. sep. 2026 · NCT07476287

A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)

Vključevanje udeležencevFaza 3
  • White Plains Hospital ( Site 0091), White Plains · 4 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06312137

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • Hematology Oncology Associates of Rockland, Nyack · 6 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT07222566

This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

Vključevanje udeležencevFaza 3
  • Hematology Oncology Associates of Rockland, Nyack · 6 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 25. sep. 2026 · NCT06758401

A Registry for People With Lung Cancer

Vključevanje udeležencevOpazovalna študija
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 24. sep. 2026 · NCT06424327

A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion

Vključevanje udeležencevFaza 2/3
  • WMCHealth Advanced Physician Services, Hawthorne · 6 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 23. sep. 2026 · NCT07063745

Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer

Vključevanje udeležencevFaza 2/3
  • White Plains Hospital, White Plains · 4 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 22. sep. 2026 · NCT06712316

Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer

Vključevanje udeležencevFaza 3
  • White Plains Hospital, White Plains · 4 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 1. sep. 2026 · NCT06712355

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small Cell Lung Cancer

Vključevanje udeležencevFaza 3
  • Westchester Medical Center, Valhalla · 5 mi stran
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT05624996

Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial

Vključevanje udeležencevFaza 3
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 17. avg. 2026 · NCT06500481

A Study of Lung Cancer Risk

Vključevanje udeležencevOpazovalna študijaVabljeni zdravi prostovoljci
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi stran
Starost 40–74 · Vsi spoli · Posodobljeno 14. avg. 2026 · NCT07701733

A Study of a Side Effects and Resource Navigation Program for People With Cancer

Vključevanje udeležencev
  • Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 31. jul. 2026 · NCT07646847

A Study of Stereotactic Radiosurgery (SRS) for People With Lung Cancer That Has Spread to the Brain

Vključevanje udeležencevFaza 2
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi stran
Starost 18 in več · Vsi spoli · Posodobljeno 10. jun. 2026 · NCT05419076

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

Vključevanje udeležencevFaza 2
  • Memorial Sloan Kettering Bergen, Montvale · 9 mi stran
18 Minutes · Vsi spoli · Posodobljeno 5. maj 2026 · NCT06031688

Študije za Rak pljuč v drugih mestih

Druge študije v Greenburgh

Vir: ClinicalTrials.gov, podatki pridobljeni 6. okt. 2026. Vsaka študija ima svoje pogoje vključitve; ekipa študije odloči, kdo lahko sodeluje.